Abstract
The fate of disseminated tumor cells in the circulation is largely determined by their physiochemical surface properties which are foreign to the blood and conditioned by the thromboplastic activities intrinsic to the tumor cell (1). The term “cancer cell stickiness” (2) describes a tumor-specific, population-variable property of the circulating tumor cells in terms of an increased tendency to adhere to foreign surfaces (3). Cell populations with a high degree of stickiness have a correspondingly high thromboplastic activity and transplantation rate (4,5).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Gastpar H. ted. Welt 27: 1737–1741, 1976.
Coman DR. Gmcer Res. 21: 1336–1338, 1961.
Strauli P. Thromb. DLathes. Haemorrh. Suppl. 20: 147–160, 1966.
Koike A. Cancer (Philadelphia) 17: 450–460, 1964.
Kojima K and Sakai I. Cancer Res. 24: 1887–1891, 1964.
Gastpar H. Hematol. Rev. 3: 1–51, 1972.
Gastpar H. Thrombos. Diath. Haemorrh. Suppl. 42: 291–303, 1970.
Gastpar H, Graeber F, Herrmann A and Loebell E. Arch. Ohren Nasen Kehlkopfheilkd. 178: 534, 1961.
Wbod S Jr., Holyoke ED and Yardley JH. Proc. Can. Cancer Res. Conf. 4: 167–223, 1961.
Jones DS, Wallace AC and Frazer EE. J. Natl. Cancer Inst. 46: 493, 1971.
Warren BA and Vales O. Br. J. Exp. Pathol. 53: 301–313, 1972.
Hilgard P. Br. J. Cancer 28: 429–453, 1973.
Abrahamsen AF. Z. Krebsforsch 86: 109–111, 1976.
Cowan EH and Graham J. Prog. CLin. Biol. Ras. 89: 249–266, 1982.
Hara Y, Steiner M and Baldini MG. Cancer Res. 40: 1212–1216, 1980.
Lipton A, Kepner N, Rogers C, Witkoski E and Leitzel K. Prog. Clin. Biol. Res. 89: 233–246, 1982.
Gasic GJ, Catalfamo JL, Gasic TB and Avdalovic N. In: Malignancy and the Hemostatic System (Eds. Donati MB, Davidson JF and Garattini S), Raven Press, New York, pp. 27–36, 1981.
Gasic G and Gasic T. Proc. Natl. Azad. Sci. USA 48: 1172–1177, 1962.
Gasic G, Gasic T and Stewart C. Proc. Natl. Acad. Sci. USA 61: 46–52, 1968.
Gastpar H. In: Neue Aspekte der Krebsbekampfung (Ed. Krokowski E), Thieme, Stuttgart, pp. 111–130, 1979.
Gastpar H. Fortschr. Med. 91: 1322–1328, 1973.
Gastpar H. Thromb. Res. 5: 277–290, 1974.
Gastpar H. Fortschr. Med. 96: 1823–1827, 1978.
Gastpar H. Ann. Chir. Gynaecol. Fenn. 71: 142–150, 1982.
Ambrus JL, Ambrus CM and Gastpar H. J. Med. 9: 183–186, 1978.
Anbrus JL, Ambrus CM, Gastpar H and Williams P. J. Med. 13: 35–247, 1982.
Gastpar H, Ambrus JL and Ambrus CM. J. Med. 9: 265–268, 1978.
Gastpar H, Ambrus JL and Thurber LE. J. Med. 8: 53–56, 1977.
Schneider W. In: Platelets: Production, function, Transfusion and Storage (Eds. Baldini MS and Ebbe S), Grune & Stratton, New York, pp. 177–185, 1974.
Reuter H and Gross R. In: Collagen Platelet Interaction (Ed. Gastpar H), Schattauer, Stuttgart, pp. 87–94, 1978.
Salzmann EW and Weisenberger H. Adv. Cyclic Nucleotide Res. 1: 231, 1972.
Stefanovich V. Res. Commun. Chem. Pathol. Pharmacol. 5: 655, 1973.
Amer MS and Mayol RF. Biochim. Biophys. Acta 309: 149–156, 1973.
Blass KE, Block HU, Forster W and Pdnicke K. Br. J. Pharmacol. 68: 71–73, 1980.
Massoti G, Poggesi G, Galanti G and Neri Serneri G. In: Collagen Platelet Interaction (Ed. Gastpar H), Schattauer, Stuttgart, pp. 87–94, 1978.
WeithnannKU. IRCS ted. Sci.-Biochem. 8: 293–294, 1980.
Carreras LO, Chamone DAF, KLerckx P and Vermylen J. Thromb. Res. 19: 663–670, 1980.
Iversen OH. In: Haneostatic Regulator (Eds. Wblstenhome GEW and Knight J), Churchill, London, pp. 29, 1969.
Sheppard JR. Nature (London) 236: 14–18, 1972.
Heidrick ML and Ryan WL. Cancer Res. 30: 376–378, 1970.
Smets LA. Nature (London) New Biol. 239: 123, 1972.
Wijk R van, Wicks WD and Clay K. Cancer Res. 32: 1905–1911, 1972.
Gericke D and Chandra P. Hoppe-Seylers Z. Physiol. Chem. 350: 1469–1471, 1969.
Keller R. Life Sci. 11: 485–500, 1972.
Ryan WL and Heidrick ML. Science 162: 1484–1492, 1968.
Johnson GS, Friedman RM and Paston I. Proc. Natl. Acad. Sci. USA 68: 425–429, 1971.
Sheppard JR. Proc. Natl. Acad. Sci. USA 68: 1316–1320, 1971.
Hait WN and Weiss B. Biochim. Biophys. Acta. 497: 86–100, 1977.
Stefanovich V, Ambrus JL, Ambrus CM, Karakousis C and Takita H. J. Med., (in press).
Ambrus JL, Ambrus CM, Gastpar H, Huberman E, tentagna R, Biddle W, Leong S and Horoszewicz J. Prog. Clin. Biol. Res. 89: 97–111, 1982.
Biddle W, Montagna RA, Leong SS, Horoszewicz J, Gastpar H and Ambrus JL. Pathol. Biol., (in press).
Ambrus JL, et al. unpublished experimental data.
Gordon S, Witful M, Cohen C, Williams P, Gastpar H, Murphy GP and Ambrus JL. J. Med. 10: 435–443, 1979.
Cutler SJ and Ederer F. J. Chronic Dis. 8: 699, 1961.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Martinus Nijhoff Publishing, Boston
About this chapter
Cite this chapter
Gastpar, H., Ambrus, J.L., van Eimeren, W. (1984). Experimental and Clinical Experience with Pyrimido-Pyrimidine Derivatives in the Inhibition of Malignant Metastasis Formation. In: Honn, K.V., Sloane, B.F. (eds) Hemostatic Mechanisms and Metastasis. Developments in Oncology, vol 22. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-3831-4_26
Download citation
DOI: https://doi.org/10.1007/978-1-4613-3831-4_26
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-3833-8
Online ISBN: 978-1-4613-3831-4
eBook Packages: Springer Book Archive